Literature DB >> 1977595

MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease.

M Morelli1, G Di Chiara.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977595     DOI: 10.1016/0014-2999(90)90066-f

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  20 in total

1.  Modulation of MK-801 response by dopaminergic agents in mice.

Authors:  A Verma; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Interaction between glutamatergic and dopaminergic tone in the nucleus accumbens of mice: evidence for a dual glutamatergic function with respect to psychomotor control.

Authors:  A Svensson; M L Carlsson; A Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1992

3.  The muscarine antagonist methscopolamine and the NMDA antagonist AP-5 injected unilaterally into the nucleus accumbens cause mice to rotate in opposite directions.

Authors:  A Svensson; M L Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1995

4.  Functional interaction between mGlu 5 and NMDA receptors in a rat model of Parkinson's disease.

Authors:  Nathalie Turle-Lorenzo; Nathalie Breysse; Christelle Baunez; Marianne Amalric
Journal:  Psychopharmacology (Berl)       Date:  2005-02-22       Impact factor: 4.530

5.  Blockade ofNMDA receptors differentially affectsD-1 andD-2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson.

Authors:  M Morelli; S Fenu; A Pinna; A Cozzolino; G Di Chiara
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

6.  The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.

Authors:  K Wedzony; A Czyrak; M Maćkowiak; K Fijał
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

7.  Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice.

Authors:  B Stauch Slusher; K C Rissolo; P F Jackson; L M Pullan
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.

Authors:  R Dall'Olio; R Rimondini; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

9.  Antidepressant drugs increase the locomotor hyperactivity induced by MK-801 in rats.

Authors:  J Maj; Z Rogóz; G Skuza
Journal:  J Neural Transm Gen Sect       Date:  1991

10.  NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats.

Authors:  John E Kelsey; Stephen D Mague; Reyna S Pijanowski; Ryan C Harris; Nancy W Kleckner; Russell T Matthews
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.